|
1. Biologie
|
|
|
|
|
|
3. Prévention
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
|
|
4.1 Dép., diag. & prono. - Prostate
|
|
|
|
4.10 Dép., diag. & prono. - FDA, EMA, NICE,...
|
|
|
Roche Receives FDA Approval for cobas KRAS Mutation Test [Roche]
|
|
|
|
|
|
The
cobas KRAS Mutation Test is a TaqMelt assay; a polymerase chain
reaction (PCR)-based diagnostic test intended for the detection of
mutations in codons 12 and 13 of the KRAS gene. The test can be
performed in less than eight hours, so physicians can make treatment
decisions quickly and confidently.
|
|
|
|
|
|
|
4.10 Dép., diag. & prono. - Poumon
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
|
|
|
4.9 Dép., diag. & prono. - Sein
|
|
|
ACP Internist: Where are we now with breast cancer screening? [ACP Internist]
|
|
|
|
|
|
When
a very subtle abnormality is noted on a screening mammogram women are
often presented with the option of a biopsy vs. waiting 6 to 12 months
and just repeating the mammogram to see if the abnormality changes. Many
women assume that the biopsy will provide an immediate answer; our
study shows that may not be the case, as these biopsies are difficult to
evaluate.
|
|
|
|
|
|
|
5. Traitements
|
|
|
|
|
5.2 Pharma
|
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
5.2.2 Pharma - Fusions & Acquisitions
|
|
|
Gilead Sciences Acquires EpiTherapeutics [Gilead]
|
|
|
|
|
|
EpiTherapeutics
has generated a library of first-in-class, selective small molecule
inhibitors of epigenetic regulation of gene transcription, in particular
histone demethylases. The company’s lead pre-clinical compounds are
being studied for the treatment of certain cancers.
|
|
|
|
|
|
|
5.3 Traitements - FDA, EMA,...
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
|
5.5 ASCO
|
|
|
|
5.6 ESMO
|
|
|
|
|
|
|
|
|
|
|
|
|
6.1 Observation
|
|
|
|
6.10 Politiques
|
|
|
|
|
6.11 Patients
|
|
|
|
|
6.4 Médico-éco
|
|
|
Health Care Forum [The Economist]
|
|
|
|
|
|
Through
The Economist's distinct lens of rigorous analysis and foresight, The
Health Care Forum, War on Cancer event, will explore the future of
health systems design, technological innovation, provision and finance.
|
|
|
|
|
|
|
6.7.1 Bioinformatique
|
|
|
The Big Data Addiction—NGS Has It Bad [GEN]
|
|
|
|
|
|
What
can be agreed upon is that there are plenty of areas of NGS that
require standardization for it to live up to its potential as an
extremely powerful tool for use in clinical medicine.
|
|
|
|
|
6.7.2 Applis
|
|
|
|